60 Degrees Pharmaceuticals I
13F holders, Q1 2025 (March 31)6holders
$1.82avg. 13F price*
At the end of Q1 2025, 6 institutions reported holding 60 Degrees Pharmaceuticals I in their 13F filings. The largest holders were UBS Group AG ($30K), Geode Capital Management, LLC ($21K) and Tower Research Capital LLC (TRC) ($3K).
- Company
- 60 Degrees Pharmaceuticals I
- CUSIP
- 83006G401
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $55K |
| Exits | 0 | $0 |
Ownership 6 holders
| UBS Group AG | 0.00% | New | 16,188 | $30K |
| Geode Capital Management, LLC | 0.00% | New | 11,924 | $21K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,550 | $3K |
| Safe Harbor Fiduciary, LLC | 0.00% | New | 275 | $506 |
| Osaic Holdings, Inc. | 0.00% | New | 100 | $184 |
| Bank of America Corp. | 0.00% | New | 12 | $22 |
"% of holder's portfolio" is 60 DEGREES PHARMACEUTICALS I's weight in each manager's 13F, not the share of 60 Degrees Pharmaceuticals I the manager owns.